{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:13:55Z","timestamp":1787494435880,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2023 Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province","award":["STKJ2023003"],"award-info":[{"award-number":["STKJ2023003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51503-0","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T08:35:25Z","timestamp":1777797325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["C-reactive protein-triglyceride glucose index as a predictor of heart failure risk in adults with MASLD: a prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Haixiang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Motzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavino","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Antonio","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2921-7583","authenticated-orcid":false,"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-1272","authenticated-orcid":false,"given":"Gianpaolo","family":"Vidili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-3279","authenticated-orcid":false,"given":"Youren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"key":"51503_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese, G. et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc. Res. 118, 3272\u20133287 (2023).","journal-title":"Cardiovasc. Res."},{"key":"51503_CR2","doi-asserted-by":"publisher","unstructured":"Yang, Q. et al. Changing patterns of heart failure in China from 1990 to 2021: a secondary analysis of the global burden of disease study 2021. Eur. Heart J. Qual. Care Clin. Outcomes. qcaf064 https:\/\/doi.org\/10.1093\/ehjqcco\/qcaf064 (2025).","DOI":"10.1093\/ehjqcco\/qcaf064"},{"key":"51503_CR3","first-page":"364","volume":"6","author":"D Banerjee","year":"2013","unstructured":"Banerjee, D. et al. Insulin resistance and risk of incident heart failure: cardiovascular health study. Circ. : Heart Fail. 6, 364\u2013370 (2013).","journal-title":"Circ. : Heart Fail."},{"key":"51503_CR4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy, S. P., Kakkar, R., McCarthy, C. P. & Januzzi, J. L. Inflammation in heart failure. J. Am. Coll. Cardiol. 75, 1324\u20131340 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"51503_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","volume":"118","author":"C Riehle","year":"2016","unstructured":"Riehle, C. & Abel, E. D. Insulin signaling and heart failure. Circ. Res. 118, 1151\u20131169 (2016).","journal-title":"Circ. Res."},{"key":"51503_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","volume":"117","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella, G. G., Rodolico, D. & Hill, J. A. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc. Res. 117, 423\u2013434 (2021).","journal-title":"Cardiovasc. Res."},{"key":"51503_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"51503_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao, L., Targher, G., Byrne, C. D., Cao, Y. Y. & Zheng, M. H. Current status and future trends of the global burden of MASLD. Trends Endocrinol. Metab. 35, 697\u2013707 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"51503_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams, L. A., Anstee, Q. M., Tilg, H. & Targher, G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66, 1138\u20131153 (2017).","journal-title":"Gut"},{"key":"51503_CR10","doi-asserted-by":"publisher","first-page":"e021654","DOI":"10.1161\/JAHA.121.021654","volume":"10","author":"M Fudim","year":"2021","unstructured":"Fudim, M. et al. Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries. J. Am. Heart Assoc. 10, e021654 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"51503_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/gutjnl-2022-327672","volume":"72","author":"A Mantovani","year":"2023","unstructured":"Mantovani, A. et al. Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals. Gut 72, 372\u2013380 (2023).","journal-title":"Gut"},{"key":"51503_CR12","doi-asserted-by":"publisher","unstructured":"Bansal, B., Lajeunesse-Trempe, F., Keshvani, N., Lavie, C. J. & Pandey, A. Impact of metabolic dysfunction\u2013associated steatotic liver disease on cardiovascular structure, function, and the risk of heart failure. Can. J. Cardiol. S0828282X25003150 https:\/\/doi.org\/10.1016\/j.cjca.2025.04.012 (2025).","DOI":"10.1016\/j.cjca.2025.04.012"},{"key":"51503_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","volume":"22","author":"A Khalaji","year":"2023","unstructured":"Khalaji, A. et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc. Diabetol. 22, 244 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"51503_CR14","doi-asserted-by":"publisher","first-page":"105786","DOI":"10.1016\/j.ebiom.2025.105786","volume":"117","author":"A Hartley","year":"2025","unstructured":"Hartley, A. et al. The relationship of baseline high-sensitivity C-reactive protein with incident cardiovascular events and all-cause mortality over 20 years. Ebiomedicine 117, 105786 (2025).","journal-title":"Ebiomedicine"},{"key":"51503_CR15","doi-asserted-by":"publisher","first-page":"26363","DOI":"10.1038\/s41598-025-08389-1","volume":"15","author":"N Cheng","year":"2025","unstructured":"Cheng, N., Ma, Z., Chen, Y., Jin, L. & Chen, L. C-reactive protein-triglyceride glucose index and heart failure in US adults from NHANES 2001\u20132010. Sci. Rep. 15, 26363 (2025).","journal-title":"Sci. Rep."},{"key":"51503_CR16","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Association between the C-reactive protein- triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovascular Diabetology 24, 316 (2025).","DOI":"10.1186\/s12933-025-02876-5"},{"key":"51503_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun, Y. et al. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc. Diabetol. 24, 313 (2025).","journal-title":"Cardiovasc. Diabetol."},{"key":"51503_CR18","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.jacc.2020.04.038","volume":"75","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J. Am. Coll. Cardiol. 75, 2921\u20132930 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"51503_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12933-022-01577-7","volume":"21","author":"Z Huang","year":"2022","unstructured":"Huang, Z. et al. Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study. Cardiovasc. Diabetol. 21, 141 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"51503_CR20","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes:standards of medical care in diabetes\u20142019. Diabetes Care 42, S13\u2013S28. (2019).","DOI":"10.2337\/dc19-S002"},{"key":"51503_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12872-018-0877-2","volume":"18","author":"J Zheng","year":"2018","unstructured":"Zheng, J. et al. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old. BMC Cardiovasc. Disord. 18, 147 (2018).","journal-title":"BMC Cardiovasc. Disord"},{"key":"51503_CR22","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"51503_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the, L","year":"2024","unstructured":"European Association for the Study of the, L. European Association for the Study of, D. & European Association for the Study of, O. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81, 492\u2013542 (2024).","journal-title":"J. Hepatol."},{"key":"51503_CR24","doi-asserted-by":"publisher","first-page":"905266","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan, G. T. et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front. Endocrinol. 13, 905266 (2022).","journal-title":"Front. Endocrinol."},{"key":"51503_CR25","doi-asserted-by":"crossref","unstructured":"Zheng, H. et al. Association between arterial stiffness and new-onset heart failure: the kailuan study. Arterioscler Thromb. Vasc Biol 43, 2 (2023).","DOI":"10.1161\/ATVBAHA.122.317715"},{"key":"51503_CR26","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42, 3599\u20133726 (2021).","journal-title":"Eur. Heart J."},{"key":"51503_CR27","first-page":"235","volume":"52","author":"Chinese Society of Cardiology of the Chinese Medical Association; Cardiovascular Department Physicians Branch of the Chinese Medical Doctor Association; Heart Failure Committee of the Chinese Medical Doctor Association","year":"2024","unstructured":"Chinese Society of Cardiology of the Chinese Medical Association; Cardiovascular Department Physicians Branch of the Chinese Medical Doctor Association; Heart Failure Committee of the Chinese Medical Doctor Association. Editorial Board of Chinese Journal of Cardiology. China Guideline for the Diagnosis and Treatment of Heart Failure 2024. Zhonghua Xin Xue Guan Bing Za Zhi. 52, 235\u2013275 (2024).","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"51503_CR28","doi-asserted-by":"publisher","first-page":"24687","DOI":"10.1038\/s41598-025-10184-x","volume":"15","author":"N Tang","year":"2025","unstructured":"Tang, N. et al. Association of C reactive protein triglyceride glucose index with mortality in coronary heart disease and type 2 diabetes from NHANES data. Sci. Rep. 15, 24687 (2025).","journal-title":"Sci. Rep."},{"key":"51503_CR29","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","volume":"119","author":"L Da Dalt","year":"2023","unstructured":"Da Dalt, L., Cabodevilla, A. G., Goldberg, I. J. & Norata, G. D. Cardiac lipid metabolism, mitochondrial function, and heart failure. Cardiovasc. Res. 119, 1905\u20131914 (2023).","journal-title":"Cardiovasc. Res."},{"key":"51503_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fphys.2020.00551","volume":"11","author":"GF Clough","year":"2020","unstructured":"Clough, G. F. et al. Dysregulated neurovascular control underlies declining microvascular functionality in people with non-alcoholic fatty liver disease (NAFLD) at risk of liver fibrosis. Front. Physiol. 11, 551 (2020).","journal-title":"Front. Physiol."},{"key":"51503_CR31","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/s41440-024-01708-5","volume":"47","author":"Y Hu","year":"2024","unstructured":"Hu, Y. et al. Temporal relationship between hepatic steatosis and blood pressure elevation and the mediation effect in the development of cardiovascular disease. Hypertens. Res. 47, 1811\u20131821 (2024).","journal-title":"Hypertens. Res."},{"key":"51503_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui, C. et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc. Diabetol. 23, 156 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"51503_CR33","doi-asserted-by":"publisher","first-page":"30403","DOI":"10.1038\/s41598-024-80801-8","volume":"14","author":"K Dong","year":"2024","unstructured":"Dong, K., Zheng, Y., Wang, Y. & Guo, Q. Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD. Sci. Rep. 14, 30403 (2024).","journal-title":"Sci. Rep."},{"key":"51503_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejim.2025.05.018","volume":"138","author":"H Abdallah","year":"2025","unstructured":"Abdallah, H. et al. Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits. Eur. J. Intern. Med. 138, 101\u2013111 (2025).","journal-title":"Eur. J. Intern. Med."},{"key":"51503_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12933-025-02758-w","volume":"24","author":"X Gao","year":"2025","unstructured":"Gao, X. et al. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovasc. Diabetol. 24, 200 (2025).","journal-title":"Cardiovasc. Diabetol."},{"key":"51503_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao, Y., Wang, Y., Chen, C., Huang, Y. & Zhao, C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK biobank. Cardiovasc. Diabetol. 24, 12 (2025).","journal-title":"Cardiovasc. Diabetol."},{"key":"51503_CR37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/gutjnl-2022-328105","volume":"72","author":"TG Simon","year":"2023","unstructured":"Simon, T. G. et al. Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease. Gut 72, 573\u2013580 (2023).","journal-title":"Gut"},{"key":"51503_CR38","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1038\/s41598-025-89293-6","volume":"15","author":"GE Chung","year":"2025","unstructured":"Chung, G. E. et al. Metabolic dysfunction-associated steatotic liver disease increases cardiovascular disease risk in young adults. Sci. Rep. 15, 5777 (2025).","journal-title":"Sci. Rep."},{"key":"51503_CR39","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1111\/dom.15733","volume":"26","author":"J Wang","year":"2024","unstructured":"Wang, J., Zheng, Z. & Zhang, Y. Association of overweight\/obesity and overweight\/obesity-related metabolic dysfunction\u2010associated steatotic liver disease in young adults with coronary artery calcification later in life. Diabetes Obes. Metab. 26, 3860\u20133867 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"51503_CR40","doi-asserted-by":"publisher","first-page":"e010841","DOI":"10.1161\/CIRCHEARTFAILURE.123.010841","volume":"17","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. Sex and Age Differences in the Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Heart Failure: A Prospective Cohort Study. Circ. Heart Fail. 17, e010841 (2024).","journal-title":"Circ. Heart Fail."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51503-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51503-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51503-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:38:12Z","timestamp":1783060692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51503-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51503"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51503-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Ethics Committee of the Kailuan General Hospital Trial (registration number: ChiCTR-TNC-11001489) and complied with the ethical principles of the Declaration of Helsinki. All the participants provided informed consent before being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"20446"}}